ENDEAVOR

Striving to improve the quality of life of Barrett’s Esophagus patients.

Find out more about our research
For Patients
For Researchers
Endeavor-784x624-01

Welcome

WHAT is the ENDEAVOR research project?

ENDEAVOR is an EU-funded research project of 5 years carried out by a consortium of 15 academic partners, 2 general hospitals and 2 industrial partners. It aims to implement an innovative risk stratification method: we want to better determine which Barrett’s esophagus (BE) patients are at risk to develop more invasive cancer and may poorly respond to endoscopic therapy. Like that, we will be able to direct the best treatment and select the most optimal subsequent surveillance program for each patient.

Read more
Endeavor-784x624-01

Welcome

WHAT is the ENDEAVOR research project?

ENDEAVOR is an EU-funded research project of 5 years carried out by a consortium of 15 academic partners, 2 general hospitals and 2 industrial partners. It aims to implement an innovative risk stratification method: we want to better determine which Barrett’s esophagus (BE) patients are at risk to develop more invasive cancer and may poorly respond to endoscopic therapy. Like that, we will be able to direct the best treatment and select the most optimal subsequent surveillance program for each patient.

Read more

Funded by the European Union

The Endeavor research project has received funding from the European Union’s Horizon EU research and innovation programme under grant agreement number: 101136935*.

* Disclaimer: “Funded by the European Union. Views and opinions expressed are, however, those of the author(s) only and do not necessarily reflect those of the European Union or the Health and Digital Executive Agency. Neither the European Union nor the granting authority can be held responsible for them.”

Depositphotos_685111902_S-784

Endeavor EU Follow

ENDEAVOR is an EU-funded research project aiming to improve the quality of life and care of patients with Barrett's Esophagus in Europe #EUfunded #HorizonEU

EndeavorEU
endeavoreu Endeavor EU @endeavoreu ·
8 Jul

Meet the Endeavor PhD students! 💥

👀Happy to introduce Piotr Twardowski, PhD candidate at @amsterdamumc

🔍 Piotr will use scientific literature and Barrett's registries to build an economic model for cost-effectiveness analysis of Barrett surveillance strategies.

#HorizonEU

Reply on Twitter 1942476931586281874 Retweet on Twitter 1942476931586281874 Like on Twitter 1942476931586281874 Twitter 1942476931586281874
endeavoreu Endeavor EU @endeavoreu ·
30 Jun

Meet the Endeavor PhD students! 💥

👀Happy to introduce Nastaran Riahi, PhD candidate at Antwerp University.

🔍 Nastaran will analyze cfDNA from Endeavor blood samples using targeted methylation sequencing and integrate these results with tissue mutation data.

#HorizonEU #PhD

Reply on Twitter 1939568331469844962 Retweet on Twitter 1939568331469844962 1 Like on Twitter 1939568331469844962 1 Twitter 1939568331469844962
endeavoreu Endeavor EU @endeavoreu ·
23 Jun

Meet the Endeavor PhD students! 💥

👀Happy to introduce Costanza Di Patrizi, PhD candidate at Antwerp University.

🔍 Costanza focuses on enhancing #QoL and care experiences for people dealing with Barrett’s Esophagus and early esophageal cancer.

#EndeavorEU #HorizonEU #PhD

Reply on Twitter 1937031616578428936 Retweet on Twitter 1937031616578428936 1 Like on Twitter 1937031616578428936 1 Twitter 1937031616578428936
endeavoreu Endeavor EU @endeavoreu ·
16 Jun

Meet the Endeavor PhD students! 💥

👀Happy to introduce Henrik Maltzman, PhD candidate at Karolinska University Hospital.

🔍 Henrik focuses on different areas of upper GI cancer, where endoscopy plays an active part.

#EndeavorEU #HorizonEU #PhD #KarolinskaUniversityHospital

Reply on Twitter 1934494901410078818 Retweet on Twitter 1934494901410078818 Like on Twitter 1934494901410078818 Twitter 1934494901410078818
Load More